Ananda Pharma Plc (AQSE:ANA) told investors it has appointed Viridian Capital Advisors to advance its US market strategy.
The firm, based in New York and Aspen, specializes in the cannabis and CBD sectors, advising companies, helping raise capital and driving strategic growth.
“We are delighted to partner with Viridian Capital Advisors,” chief executive Melissa Sturgess said in a statement.
“Their proven track record in the cannabis sector and extensive network within the US investment community will be invaluable as we build our profile in the US market.
“The US market is the largest for cannabinoid-based pharmaceuticals and offers a dynamic investment landscape well-suited to our goals."